Effects of SAMe, MTA, miR-34a and miR-34b on MAT2A and MAT2B

A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy

Maria TOMASI, Professor (Assistant), Molecular Pathology, Ph.D, Cedars-Sinai Medical Center, Los Angeles, Department of Medicine

Epigenomes, Free Full-Text

Ainhoa IGLESIAS, Professor (Associate), Biochemistry, Universidad del País Vasco / Euskal Herriko Unibertsitatea, Leioa, UPV/EHU, Departamento de Genética, Antropología Física y Fisiología Animal

Dynamical modeling of miR-34a, miR-449a, and miR-16 reveals numerous DDR signaling pathways regulating senescence, autophagy, and apoptosis in HeLa cells

Role of miR‑34 in gastric cancer: From bench to bedside (Review)

Frontiers Role of microRNA-34a in blood–brain barrier permeability and mitochondrial function in ischemic stroke

Ainhoa IGLESIAS, Professor (Associate), Biochemistry, Universidad del País Vasco / Euskal Herriko Unibertsitatea, Leioa, UPV/EHU, Departamento de Genética, Antropología Física y Fisiología Animal

New insights on the role of epigenetic alterations in hepatocellular c

Keep a watchful eye on methionine adenosyltransferases, novel therapeutic opportunities for hepatobiliary and pancreatic tumours - ScienceDirect

miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells, BMC Cancer

Ekihiro SEKI, Professor, M.D., Ph.D., Cedars-Sinai Medical Center, Los Angeles, Department of Medicine

Frontiers Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases

MiR-34 and MiR-200: Regulator of Cell Fate Plasticity and Neural Development

miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cells, Cancer Cell International